Massive pulmonary embolism presenting with acute hemiparesis and aphasia: a case report of paradoxical embolism documented with transthoracic echocardiography

    Authors

    Abstract

    **Introduction**: Prevalence of patent foramen ovale (PFO) is somewhere between 20 to 30% in general adult population. It is mostly asymptomatic, but specific circumstances like acute or transient right heart pressure elevation can cause interatrial shunting and consequent paradoxical embolism. It is defined by occurrence of systemic embolism in the context of deep vein thrombosis or pulmonary embolism. Cardiogenic source of embolism accounts for approximately 20% of ischemic strokes, of which at least some portion is considered to be associated with PFO, atrial septal defect or atrial septal aneurysm. Still, PFO in the context of ischemic stroke does not necessary prove causal relationship between two (can be “innocent bystander”). (1-4) **Case report**: 54-years-old male patient presented to the Emergency Care Unit with acute development of right-sided hemiparesis, aphasia and worsening of dyspnea lasting for couple of days. Urgently, computed tomography (CT) of brain was performed, which initially showed no signs of cerebral ischemia or hemorrhage. Transthoracic echocardiography was performed and acute right heart dilatation with flattening of interventricular septum was visualized, with systolic pulmonary pressure measuring 90 mmHg suggesting acute pulmonary embolism. Also, large thrombotic masses floating in the right atrium, passing into the right ventricle through tricuspid valve were visualized, with large thrombus trapped in PFO, showing pending paradoxical embolism (**Figure 1**, **Figure 2**). CT pulmonary angiogram confirmed massive pulmonary embolism. Systemic fibrinolytic therapy was administered with complete resolution of thromboembolic masses in the heart but with persisting neurological deficit. CT angiography of brain was performed, and acute medial cerebral artery occlusion was visualized. Urgent thrombectomy was performed. Subsequently deep vein thrombosis of lower limb was found. During first 4 weeks anticoagulant therapy imposed significant risk and inferior vena cava (VCI) filter was implanted. After device explantation, long term anticoagulant therapy was continued. Patient is regarded to be a candidate for PFO occlusion device implantation in the future. FIGURE 1. Large thrombus floating in the right atrium and right heart dilatation. FIGURE 2. Large thrombotic masses passing through patent foramen ovale as a sign of paradoxical embolism. **Conclusion**: For secondary prevention of systemic embolism and stroke in patients with PFO antiplatelet or anticoagulant therapy or PFO occlusion device implantation seem to be reasonable options. Decision about treatment option is made depending on patient age, risk factors, other possible sources of embolism and atrial septal anomaly characteristics.

    Keywords

    paradoxical embolism, patent foramen ovale, acute ischemic stroke

    DOI

    https://doi.org/10.15836/ccar2021.190

    Literature

    1. Pristipino C, Sievert H, D’Ascenzo F, Louis Mas J, Meier B, Scacciatella P, et al. Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019 October 7;40(38):3182–95. https://doi.org/10.1093/eurheartj/ehy649
    2. Pristipino C, Germonpré P, Toni D, Sievert H, Meier B, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. Eur Heart J. 2021 January 28;•••:ehaa1070. [Online ahead of print.]. https://doi.org/10.1093/eurheartj/ehaa1070
    3. Guo S, Roberts I, Missri J. Paradoxical embolism, deep vein thrombosis, pulmonary embolism in a patient with patent foramen ovale: a case report. J Med Case Reports. 2007 September 25;1:104. https://doi.org/10.1186/1752-1947-1-104
    4. Barrios DD, Roncancio J, Avila AA, Alvarado JA, Montenegro AC. Paradoxical Embolism due to Persistent Foramen Ovale; a Case Report. Emerg (Tehran). 2017;5(1):e46. https://pubmed.ncbi.nlm.nih.gov/28286853/
    Cardiologia Croatica
    Back to search

    Massive pulmonary embolism presenting with acute hemiparesis and aphasia: a case report of paradoxical embolism documented with transthoracic echocardiography

    Extended Abstract
    Issue5-6
    Published
    Pages190-191
    PDF via DOIhttps://doi.org/10.15836/ccar2021.190
    paradoxical embolism
    patent foramen ovale
    acute ischemic stroke

    Authors

    Ivana Petrović Juren*ORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Iva LadićORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Sandra PršaORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Kristina Milevoj KrižićORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Andreja Čleković-KovačićORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Renata Janković IvanacORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Gabriela BaškovićORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Vlasta Soukup PodravecORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Marina ŠimunovićORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia
    Tihana GržinčićORCIDGeneral Hospital Bjelovar, Bjelovar, Croatia

    *Correspondence email: ivanapetro@yahoo.co.uk

    Abstract

    **Introduction**: Prevalence of patent foramen ovale (PFO) is somewhere between 20 to 30% in general adult population. It is mostly asymptomatic, but specific circumstances like acute or transient right heart pressure elevation can cause interatrial shunting and consequent paradoxical embolism. It is defined by occurrence of systemic embolism in the context of deep vein thrombosis or pulmonary embolism. Cardiogenic source of embolism accounts for approximately 20% of ischemic strokes, of which at least some portion is considered to be associated with PFO, atrial septal defect or atrial septal aneurysm. Still, PFO in the context of ischemic stroke does not necessary prove causal relationship between two (can be “innocent bystander”). (1-4) **Case report**: 54-years-old male patient presented to the Emergency Care Unit with acute development of right-sided hemiparesis, aphasia and worsening of dyspnea lasting for couple of days. Urgently, computed tomography (CT) of brain was performed, which initially showed no signs of cerebral ischemia or hemorrhage. Transthoracic echocardiography was performed and acute right heart dilatation with flattening of interventricular septum was visualized, with systolic pulmonary pressure measuring 90 mmHg suggesting acute pulmonary embolism. Also, large thrombotic masses floating in the right atrium, passing into the right ventricle through tricuspid valve were visualized, with large thrombus trapped in PFO, showing pending paradoxical embolism (**Figure 1**, **Figure 2**). CT pulmonary angiogram confirmed massive pulmonary embolism. Systemic fibrinolytic therapy was administered with complete resolution of thromboembolic masses in the heart but with persisting neurological deficit. CT angiography of brain was performed, and acute medial cerebral artery occlusion was visualized. Urgent thrombectomy was performed. Subsequently deep vein thrombosis of lower limb was found. During first 4 weeks anticoagulant therapy imposed significant risk and inferior vena cava (VCI) filter was implanted. After device explantation, long term anticoagulant therapy was continued. Patient is regarded to be a candidate for PFO occlusion device implantation in the future. FIGURE 1. Large thrombus floating in the right atrium and right heart dilatation. FIGURE 2. Large thrombotic masses passing through patent foramen ovale as a sign of paradoxical embolism. **Conclusion**: For secondary prevention of systemic embolism and stroke in patients with PFO antiplatelet or anticoagulant therapy or PFO occlusion device implantation seem to be reasonable options. Decision about treatment option is made depending on patient age, risk factors, other possible sources of embolism and atrial septal anomaly characteristics.

    Literature

    1. 1.
      Pristipino C, Sievert H, D’Ascenzo F, Louis Mas J, Meier B, Scacciatella P, et al. Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019 October 7;40(38):3182–95.DOI
    2. 2.
      Pristipino C, Germonpré P, Toni D, Sievert H, Meier B, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. Eur Heart J. 2021 January 28;•••:ehaa1070. [Online ahead of print.].DOI
    3. 3.
      Guo S, Roberts I, Missri J. Paradoxical embolism, deep vein thrombosis, pulmonary embolism in a patient with patent foramen ovale: a case report. J Med Case Reports. 2007 September 25;1:104.DOI
    4. 4.
      Barrios DD, Roncancio J, Avila AA, Alvarado JA, Montenegro AC. Paradoxical Embolism due to Persistent Foramen Ovale; a Case Report. Emerg (Tehran). 2017;5(1):e46.PubMed